Literature DB >> 33160072

Effects of chemogenetic manipulation of the nucleus accumbens core in male C57BL/6J mice.

Kayla G Townsley1, Marissa B Borrego1, Angela R Ozburn2.   

Abstract

Binge drinking is a widespread public health concern with limited effective treatment options. To better select pharmaceutical targets, it is imperative to expand our knowledge of the underlying neural mechanisms involved in binge drinking. Our previous experiments in C57BL/6J female mice found that increasing activity in the nucleus accumbens (NAc) core using excitatory Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) reduced binge-like drinking. These results differed from what has been found in males; however, it is unclear whether differences in experimental procedures or sex underlie these discrepancies. We matched the conditions used in our female study and asked whether bidirectional manipulation of NAc core activity has different effects on binge-like drinking in males. Male C57BL/6J mice were stereotaxically injected with AAV2 hSyn-HA hM3Dq (excitatory), -hM4Di (inhibitory), or -eGFP bilaterally into the NAc core. We tested the effects of altering NAc activity on binge-like ethanol intake using Drinking in the Dark (DID). During the first week, mice were pre-treated with vehicle to establish baseline ethanol intake. In week 2, mice were treated with 1 mg/kg CNO prior to DID to determine the effects of DREADD-induced changes in NAc core activity on ethanol intake. Decreasing activity via CNO/hM4Di significantly decreased binge-like drinking in male mice relative to eGFP and hM4Di groups. We also measured intake of sucrose, quinine, and water after CNO treatment and found that increasing NAc core activity via CNO/hM3Dq increased quinine intake, and increased water intake over time. We did not observe significant differences in the GFP or hM4Di groups. This work suggests there exist apparent sex-related differences in NAc core contributions to binge-like alcohol drinking, thus demonstrating the need for inclusion of both sexes in future work. Published by Elsevier Inc.

Entities:  

Keywords:  DREADDs; binge drinking; chemogenetics; nucleus accumbens; sex differences

Mesh:

Substances:

Year:  2020        PMID: 33160072      PMCID: PMC8675149          DOI: 10.1016/j.alcohol.2020.10.005

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  33 in total

1.  Voluntary ethanol intake predicts κ-opioid receptor supersensitivity and regionally distinct dopaminergic adaptations in macaques.

Authors:  Cody A Siciliano; Erin S Calipari; Verginia C Cuzon Carlson; Christa M Helms; David M Lovinger; Kathleen A Grant; Sara R Jones
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

Review 2.  Sex differences in stress responses: a critical role for corticotropin-releasing factor.

Authors:  Debra A Bangasser; Kimberly R Wiersielis
Journal:  Hormones (Athens)       Date:  2018-04-16       Impact factor: 2.885

3.  Ultrastructural analysis of sex differences in nucleus accumbens synaptic connectivity.

Authors:  Anne Marie Wissman; Renee M May; Catherine S Woolley
Journal:  Brain Struct Funct       Date:  2011-10-11       Impact factor: 3.270

4.  Chronic alcohol drinking alters neuronal dendritic spines in the brain reward center nucleus accumbens.

Authors:  Feng C Zhou; Bruce Anthony; Kenneth W Dunn; W Brent Lindquist; Zao C Xu; Ping Deng
Journal:  Brain Res       Date:  2007-01-02       Impact factor: 3.252

5.  Variable effects of chronic intermittent ethanol exposure on ethanol drinking in a genetically diverse mouse cohort.

Authors:  Marcelo F Lopez; Michael F Miles; Robert W Williams; Howard C Becker
Journal:  Alcohol       Date:  2016-10-13       Impact factor: 2.405

Review 6.  Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling.

Authors:  Christian Lüscher; Robert C Malenka
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

Review 7.  Neurocircuitry of addiction.

Authors:  George F Koob; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

8.  Evaluation of short-term psychological functions in opiate addicts after ablating the nucleus accumbens via stereotactic surgery.

Authors:  Fei He; Hao Guan; Zhijing Zhao; Xinfang Miao; Qin Zhou; Lihong Li; Dongmei Huang; Anheng Liu; Danmin Miao
Journal:  Stereotact Funct Neurosurg       Date:  2008-10-08       Impact factor: 1.875

9.  Activation of nucleus accumbens NMDA receptors differentially affects appetitive or aversive taste learning and memory.

Authors:  Luis Núñez-Jaramillo; José A Rangel-Hernández; Belén Burgueño-Zúñiga; María I Miranda
Journal:  Front Behav Neurosci       Date:  2012-04-19       Impact factor: 3.558

10.  Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive.

Authors:  Julia C Lemos; Matthew J Wanat; Jeffrey S Smith; Beverly A S Reyes; Nick G Hollon; Elisabeth J Van Bockstaele; Charles Chavkin; Paul E M Phillips
Journal:  Nature       Date:  2012-09-19       Impact factor: 49.962

View more
  3 in total

1.  Characterization of DREADD receptor expression and function in rhesus macaques trained to discriminate ethanol.

Authors:  Daicia C Allen; Vanessa A Jimenez; Timothy L Carlson; Nicole A Walter; Kathleen A Grant; Verginia C Cuzon Carlson
Journal:  Neuropsychopharmacology       Date:  2021-10-15       Impact factor: 8.294

2.  Viral-Mediated Knockdown of Nucleus Accumbens Shell PAC1 Receptor Promotes Excessive Alcohol Drinking in Alcohol-Preferring Rats.

Authors:  Margaret A Minnig; Tayun Park; Maria Echeveste Sanchez; Pietro Cottone; Valentina Sabino
Journal:  Front Behav Neurosci       Date:  2021-12-03       Impact factor: 3.617

3.  Targeting the Maladaptive Effects of Binge Drinking on Circadian Gene Expression.

Authors:  Kolter Grigsby; Courtney Ledford; Tanvi Batish; Snigdha Kanadibhotla; Delaney Smith; Evan Firsick; Alexander Tran; Kayla Townsley; Kaylee-Abril Vasquez Reyes; Katherine LeBlanc; Angela Ozburn
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.